|
| 37263354 | IgA nephropathy: the lectin pathway and implications for targeted therapy. | Kidney Int | 2023 |
| 35967104 | Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria. | Kidney Int Rep | 2022 |
| 35751858 | Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease. | Am J Hematol | 2022 |
| 36404708 | Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan. | Am J Nephrol | 2022 |
| 36514397 | Association of Bradycardia and Asystole Episodes with Dialytic Parameters: An Analysis of the Monitoring in Dialysis (MiD) Study. | Kidney360 | 2022 |
| 36423588 | Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies. | Am J Nephrol | 2022 |
| 32771461 | Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection. | Am J Med | 2021 |
| 33913637 | Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD. | N Engl J Med | 2021 |
| 33913638 | Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis. | N Engl J Med | 2021 |
| 34676372 | Electrolyte Changes in Contemporary Hemodialysis: A Secondary Analysis of the Monitoring in Dialysis (MiD) Study. | Kidney360 | 2021 |
| 34386659 | The Influence of an Elastase-Sensitive Complement C5 Variant on Lupus Nephritis and Its Flare. | Kidney Int Rep | 2021 |
| 32259899 | Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection. | Rev Cardiovasc Med | 2020 |
| 33163724 | Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy. | Kidney Int Rep | 2020 |
| 33387997 | Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19). | Rev Cardiovasc Med | 2020 |
| 33380521 | Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy. | RMD Open | 2020 |
| 32603526 | Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for Treatment of Anemia in Chronic Kidney Disease: A Placebo-Controlled Study of Pharmacokinetic and Pharmacodynamic Profiles in Hemodialysis Patients. | J Clin Pharmacol | 2020 |
| 32381584 | Intradialytic Hypotension and Cardiac Arrhythmias in Patients Undergoing Maintenance Hemodialysis: Results from the Monitoring in Dialysis Study. | Clin J Am Soc Nephrol | 2020 |
| 30420324 | A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis. | Kidney Int | 2019 |
| 29395340 | Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle. | Kidney Int | 2018 |
| 29852500 | Proteinuria in Nephrotic Syndrome: Mechanistic and Clinical Considerations in Optimizing Management. | Am J Nephrol | 2018 |
| 29852493 | Protecting Podocytes: A Key Target for Therapy of Focal Segmental Glomerulosclerosis. | Am J Nephrol | 2018 |
| 30139467 | Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography. | JACC Cardiovasc Interv | 2018 |
| 29385323 | Evaluation of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy After Single and Multiple Dosings of LY3016859 in Healthy Subjects and Patients With Diabetic Nephropathy. | Clin Pharmacol Drug Dev | 2018 |
| 29509568 | Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II. | Crit Care Med | 2018 |
| 29481660 | JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial. | Nephrol Dial Transplant | 2018 |
| 27864296 | A mechanistic investigation of thrombotic microangiopathy associated with IV abuse of Opana ER. | Blood | 2017 |
| 29270498 | Safety and Efficacy of Combination ACTHar Gel and Tacrolimus in Treatment-Resistant Focal Segmental Glomerulosclerosis and Membranous Glomerulopathy. | Kidney Int Rep | 2017 |
| 29270487 | A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis. | Kidney Int Rep | 2017 |
| 28528561 | Angiotensin II for the Treatment of Vasodilatory Shock. | N Engl J Med | 2017 |
| 27821627 | A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction. | J Am Soc Nephrol | 2017 |
| 26763255 | Arrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis Study. | Clin J Am Soc Nephrol | 2016 |
| 25655065 | Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity. | J Am Soc Nephrol | 2015 |
| 26244978 | A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury. | PLoS One | 2015 |
| 26004770 | Major Adverse Events One Year After Acute Kidney Injury After Contrast-Enhanced Computed Tomography. | Ann Emerg Med | 2015 |
| 24005224 | Evaluation of 32 urine biomarkers to predict the progression of acute kidney injury after cardiac surgery. | Kidney Int | 2014 |
| 24530671 | Proposal for a functional classification system of heart failure in patients with end-stage renal disease: proceedings of the acute dialysis quality initiative (ADQI) XI workgroup. | J Am Coll Cardiol | 2014 |
| 23124782 | Randomized clinical trial of the iron-based phosphate binder PA21 in hemodialysis patients. | Clin J Am Soc Nephrol | 2013 |
| 24448253 | The role of early and sufficient isolated venovenous ultrafiltration in heart failure patients with pulmonary and systemic congestion. | Rev Cardiovasc Med | 2013 |
| 24053972 | Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. | Crit Care | 2013 |
| 24159603 | Advanced diabetic nephropathy with nephrotic range proteinuria: a pilot study of the long-term efficacy of subcutaneous ACTH gel on proteinuria, progression of CKD, and urinary levels of VEGF and MCP-1. | J Diabetes Res | 2013 |
| 24009222 | Association of elevated urinary concentration of renin-angiotensin system components and severe AKI. | Clin J Am Soc Nephrol | 2013 |
| 23689661 | Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). | Contrib Nephrol | 2013 |
| 23689657 | Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). | Contrib Nephrol | 2013 |
| 23143504 | Urinary angiotensinogen and risk of severe AKI. | Clin J Am Soc Nephrol | 2013 |
| 23106607 | The effect of the selective cytopheretic device on acute kidney injury outcomes in the intensive care unit: a multicenter pilot study. | Semin Dial | 2013 |
| 22569341 | Soluble urokinase receptor and focal segmental glomerulosclerosis. | Curr Opin Nephrol Hypertens | 2012 |
| 23095410 | Cell-based strategies for the treatment of kidney dysfunction: a review. | Blood Purif | 2012 |
| 22687176 | Prospective study of the incidence of contrast-induced nephropathy among patients evaluated for pulmonary embolism by contrast-enhanced computed tomography. | Acad Emerg Med | 2012 |
| 22442188 | Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials. | Clin J Am Soc Nephrol | 2012 |
| 22442184 | Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings. | Clin J Am Soc Nephrol | 2012 |